Literature DB >> 8120569

Localized proton spectroscopy of inoperable brain gliomas. Response to radiation therapy.

M A Heesters1, R L Kamman, E L Mooyaart, K G Go.   

Abstract

With in vivo 1H-MRS resonances of several metabolites were simultaneously measured in cerebral gliomas and adjacent normal brain. 15 patients with inoperable brain gliomas all histologically verified were monitored with 1H-MRS and MRI before and after radiotherapy. 11 patients were evaluable. 1H-MRS technique evolved from single volume measurements to one dimensional and two dimensional 1H spectroscopic imaging. In all patients N-acetyl-aspartate signals were decreased in tumour areas compared to the normal brain hemisphere. No recovery was seen after radiotherapy. Choline signals were increased in tumour margins of high grade gliomas and more diffusely in low grade gliomas. In 5 patients the choline resonance decreased after radiotherapy, accompanied by a shrinkage of tumour diameter on MRI. Lactate signals were present in high grade and unspecified astrocytomas and absent in most low grade gliomas. In 3 patients the lactate signal disappeared after radiotherapy. These observations indicate the feasibility of 1H-MRS in monitoring metabolic responses on radiotherapy of brain gliomas.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8120569     DOI: 10.1007/bf01054271

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  20 in total

1.  Uptake and metabolism of choline by rat brain after acute choline administration.

Authors:  J Klein; A Köppen; K Löffelholz; J Schmitthenner
Journal:  J Neurochem       Date:  1992-03       Impact factor: 5.372

2.  Metabolism of human gliomas: assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET.

Authors:  J R Alger; J A Frank; A Bizzi; M J Fulham; B X DeSouza; M O Duhaney; S W Inscoe; J L Black; P C van Zijl; C T Moonen
Journal:  Radiology       Date:  1990-12       Impact factor: 11.105

3.  High-resolution 1H NMR spectroscopy studies of extracts of human cerebral neoplasms.

Authors:  J Peeling; G Sutherland
Journal:  Magn Reson Med       Date:  1992-03       Impact factor: 4.668

4.  Specific expression of N-acetylaspartate in neurons, oligodendrocyte-type-2 astrocyte progenitors, and immature oligodendrocytes in vitro.

Authors:  J Urenjak; S R Williams; D G Gadian; M Noble
Journal:  J Neurochem       Date:  1992-07       Impact factor: 5.372

5.  Proton MR spectroscopy of intracranial tumours: in vivo and in vitro studies.

Authors:  S S Gill; D G Thomas; N Van Bruggen; D G Gadian; C J Peden; J D Bell; I J Cox; D K Menon; R A Iles; D J Bryant
Journal:  J Comput Assist Tomogr       Date:  1990 Jul-Aug       Impact factor: 1.826

6.  Pathologic anatomy and CT correlations in the glioblastoma multiforme.

Authors:  P C Burger
Journal:  Appl Neurophysiol       Date:  1983

7.  Computerized tomographic and pathologic studies of the untreated, quiescent, and recurrent glioblastoma multiforme.

Authors:  P C Burger; P J Dubois; S C Schold; K R Smith; G L Odom; D C Crafts; F Giangaspero
Journal:  J Neurosurg       Date:  1983-02       Impact factor: 5.115

Review 8.  Positron emission tomography in oncology. Council on Scientific Affairs.

Authors: 
Journal:  JAMA       Date:  1988-04-08       Impact factor: 56.272

9.  In vivo disturbance of the oxidative metabolism of glucose in human cerebral gliomas.

Authors:  C G Rhodes; R J Wise; J M Gibbs; R S Frackowiak; J Hatazawa; A J Palmer; D G Thomas; T Jones
Journal:  Ann Neurol       Date:  1983-12       Impact factor: 10.422

10.  Noninvasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo: initial experience in patients with cerebral tumors.

Authors:  H Bruhn; J Frahm; M L Gyngell; K D Merboldt; W Hänicke; R Sauter; C Hamburger
Journal:  Radiology       Date:  1989-08       Impact factor: 11.105

View more
  15 in total

Review 1.  On the principles underlying the diagnosis of brain tumours--a survey article.

Authors:  K G Go; R L Kamman; J Pruim; J M Hew; W Vaalburg; A M Paans; E L Mooyaart; M A Heesters; F H Lopes da Silva
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

2.  Neuroimaging in pediatric brain tumors: Gd-DTPA-enhanced, hemodynamic, and diffusion MR imaging compared with MR spectroscopic imaging.

Authors:  A Aria Tzika; Maria K Zarifi; Liliana Goumnerova; Loukas G Astrakas; David Zurakowski; Tina Young-Poussaint; Douglas C Anthony; R Michael Scott; Peter McL Black
Journal:  AJNR Am J Neuroradiol       Date:  2002-02       Impact factor: 3.825

3.  Variation of post-treatment H-MRSI choline intensity in pediatric gliomas.

Authors:  J A Lazareff; R K Gupta; J Alger
Journal:  J Neurooncol       Date:  1999-02       Impact factor: 4.130

4.  Serial proton MR spectroscopic imaging of recurrent malignant gliomas after gamma knife radiosurgery.

Authors:  E E Graves; S J Nelson; D B Vigneron; L Verhey; M McDermott; D Larson; S Chang; M D Prados; W P Dillon
Journal:  AJNR Am J Neuroradiol       Date:  2001-04       Impact factor: 3.825

5.  Preoperative proton MR spectroscopic imaging of brain tumors: correlation with histopathologic analysis of resection specimens.

Authors:  C Dowling; A W Bollen; S M Noworolski; M W McDermott; N M Barbaro; M R Day; R G Henry; S M Chang; W P Dillon; S J Nelson; D B Vigneron
Journal:  AJNR Am J Neuroradiol       Date:  2001-04       Impact factor: 3.825

6.  Proton MR spectroscopic evaluation of suspicious brain lesions after stereotactic radiotherapy.

Authors:  H P Schlemmer; P Bachert; K K Herfarth; I Zuna; J Debus; G van Kaick
Journal:  AJNR Am J Neuroradiol       Date:  2001-08       Impact factor: 3.825

Review 7.  Imaging of brain tumors: MR spectroscopy and metabolic imaging.

Authors:  Alena Horská; Peter B Barker
Journal:  Neuroimaging Clin N Am       Date:  2010-08       Impact factor: 2.264

Review 8.  Assessment of therapeutic response and treatment planning for brain tumors using metabolic and physiological MRI.

Authors:  Sarah J Nelson
Journal:  NMR Biomed       Date:  2011-04-27       Impact factor: 4.044

9.  Efficacy of proton magnetic resonance spectroscopy in clinical decision making for patients with suspected malignant brain tumors.

Authors:  A Lin; S Bluml; A N Mamelak
Journal:  J Neurooncol       Date:  1999       Impact factor: 4.130

10.  Localised proton spectroscopy and spectroscopic imaging in cerebral gliomas, with comparison to positron emission tomography.

Authors:  K G Go; R L Kamman; E L Mooyaart; M A Heesters; J Pruim; W Vaalburg; A M Paans
Journal:  Neuroradiology       Date:  1995-04       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.